NDC 0002-8400

Forteo

Teriparatide

Forteo is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Teriparatide.

• Product ID: 0002-8400_00d83295-d459-4109-8865-55f1a3b41931
• NDC: 0002-8400
• Product Type: Human Prescription Drug
• Proprietary Name: Forteo
• Generic Name: Teriparatide
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2002-11-26
• Marketing Category: NDA / NDA
• Application Number: NDA021318
• Labeler Name: Eli Lilly and Company
• Substance Name: TERIPARATIDE
• Active Ingredient Strength: 250 ug/mL
• Pharm Classes: Parathyroid Hormone [CS],Parathyroid Hormone Analog [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0002-8400-01

1 SYRINGE in 1 CARTON (0002-8400-01) > 2.4 mL in 1 SYRINGE

• Marketing Start Date: 2008-10-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0002-8400-99 [00002840099]

Forteo INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA021318
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2008-10-01
• Marketing End Date: 2021-01-31

NDC 0002-8400-01 [00002840001]

Forteo INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA021318
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2008-10-01

Drug Details

Active Ingredients

Ingredient	Strength
TERIPARATIDE	250 ug/mL

OpenFDA Data

• SPL SET ID: aae667c5-381f-4f92-93df-2ed6158d07b0
• Manufacturer:
  • Eli Lilly and Company
• UNII:
  • 10T9CSU89I
• RxNorm Concept Unique ID - RxCUI:
  • 1435115
  • 1435117

Pharmacological Class

• Parathyroid Hormone [CS]
• Parathyroid Hormone Analog [EPC]

NDC Crossover Matching brand name "Forteo" or generic name "Teriparatide"

NDC	Brand Name	Generic Name
0002-8400	Forteo	Teriparatide
47781-652	teriparatide	teriparatide